Elderly patients and patients with different comorbid conditions are at a higher risk of developing severe clinical course and lethal influenza outcome. The aim of this study was to define comorbid conditions in patients with a severe form of seasonal influenza, and to define their influence on lethal outcome. The study was a prospective, group comparison and was conducted at the University Clinic for Infectious Diseases in Skopje, Macedonia, during the period of January 01, 2012 to January 01, 2015. The study included 87 adult patients with a severe form of seasonal influenza, who were further categorized in to a group of either survived patients (n=75) and a group of deceased patients (n=12). Demographic parameters of the patients, as well as any comorbid medical conditions, such as cardiovascular disease, chronic lung disease, neurological diseases, weakened immune system, endocrine disorders, kidney disorders, liver disorders, pregnancy, overweight were noted upon admission in the hospital. The variables of the univariate analysis that showed a significant difference in terms of the outcome were used for creating multivariate logistic and regression analysis to identify independent predictors for lethal outcome in severe cases of influenza. Multivariate analysis identified cardiovascular comorbid diseases (p=0.014), as an independent predictor of the outcome in patients with severe form of seasonal influenza. Influenza patients with cardiovascular diseases had 2.024 times greater risk of death from influenza in comparison to patients having influenza without a history of such a disease (OR=2.024 95% CI 1.842-17.337).
Introduction
Influenza is a serious disease with significant morbidity and mortality which clinical presentation ranges from relatively mild and self-limiting respiratory infections to severe clinical manifestations (Thompson et al., 2009) . During seasonal epidemics from 3 to 5 million severe cases and about 250.000-500.000 lethal cases are registered worldwide (Puig-Barberà et al., 2015; World Health Organization, 2014) . Until now there has been no laboratory test that can serve as a potential marker for identification of patients with a high risk of developing severe clinical forms of influenza and lethal outcome (Blyth et al., 2009; Zimmerman et al., 2014) . It is known that elderly patients and patients with different comorbid conditions such as diabetes mellitus, chronic cardiovascular and pulmonary diseases, immunosuppressive conditions, overweight patients, pregnant women and other conditions are at a higher risk of developing severe clinical course of the disease and lethal outcome (Kalyani et al., 2011) . Although the influenza virus is primarily a respiratory pathogen, the severe clinical forms of the disease are manifested as systemic infections with multisystem organ affection, and even 10-30% of the diseased need intensive treatment (Lee et al., 2010; Mata-Marín et al., 2015; Oh et al., 2009) . Pneumonia is the most important reason for hospitalization, development of severe clinical course of the disease and lethal outcome (Woo., 2011) . In most studies delayed antiviral treatment, severe hypoxemia and multisystem organ failure are most commonly referred as leading risk factors for lethal outcome (Damak et al., 2011; Webb et al., 2009 ). The largest number of studies has evaluated isolated risk factors leading to lethal outcome and only a few of them have been focused on the complete palette of predictors for development of a severe form of the disease and lethal outcome (Kumar et al., 2009; Li et al., 2009; Liu et al., 2009; Yokota, 2011) . From the clinical practice point of view, the recognition of the risk factors and predictors for lethal outcome of influenza is of particular importance in bringing timely and exact decision for hospitalization, treatment or undertaking special measures for intensive monitoring of these patients.
Severe influenza is defined by signs of respiratory weakness (dyspnea, tachypnea, hypoxia, cyanosis) that is partial pressure of arterial oxygen (PaO2<70 mmHg;<9.0 kPa) and/or need of mechanical ventilation or signs of acute respiratory distress syndrome (PaO2/FiO2≤200), intensive care, severe complications, exacerbation of the existing chronic disease (Centers for Disease Control and Prevention, 2009-2010; World Health Organization, 2009) .
The aim of this study was to define comorbid conditions in patients with a severe form of seasonal influenza, as well as to define their influence on lethal outcome.
Material and methods
The study was prospective, clinical, group comparison and it was conducted at the Clinic for Infectious Diseases and Febrile Conditions in a three-year-period (01 Jan. 2012-01 Jan. 2015).
A total of 87 patients with severe forms of clinically and laboratory confirmed influenza were analyzed. The patients were over 16 years old, divided into two groups. Group 1 included 75 patients who survived and group 2 comprised 12 patients who had lethal outcome. Patients were excluded if they died in the first 24 hours of their inclusion in the study. On admission of patients, the following parameters were noted: demographic characteristics, comorbidities (cardiovascular disease, chronic lung disease, neurological diseases, hematological and malignant disease, immunosuppressive therapy and immunosuppressive conditions, HIV infections, asplenia, insulin dependent diabetes, chronic renal failure, hepatic cirrhosis, obesity-body mass index ≥ 40, pregnancy).
The study was designed in accordance with the ethics principles of the Declaration of Helsinki for patients and their rights, and was approved by the Ethics Committee of the Medical Faculty of Ss Cyril and Methodius University in Skopje.
Nasopharyngeal smear was used for detection of influenza virus. In the Laboratory of virology and molecular diagnosis at the Institute for Public Health from the previously isolated RNA (ribonucleic acid) real time RT-PCR (reverse transcriptase/ion-polymerase chain reaction in real time) was performed.
The data were statistically analyzed with the SPSS for Windows 13.0 program, using relevant statistical methodologies. Distribution of frequencies (absolute and relative incidence) was used for qualitative parameters. Descriptive methods such as mean, median and mode were used for mean and typical values of data as well as measures of declination, standard deviation and standard error. For testing the significance of the difference between certain analyzed factors parametric tests (t-test for independent samples, Analysis of Variance) were used and non-parametric tests for independent samples (Mann-Whitney U test, Chi -square test, Fisher-exact test).
Regarding determination of prognostic factors of death in patients with influenza the method of multivariate analysis was used (Logistic Binary Regression), by which the relation of probability of exposure (OR) was determined as an approximate value of the real risk (RR). Statistical precision (OR) was obtained by calculation of the confidence intervals (CI) about the estimated values.
The value of p<0.05 was considered to be statistically significant, and the value of p<0.01 highly significant.
Results
From a total of 87 patients 13.79% died. Our results showed that females died insignificantly more often than men (16.13% vs. 12.5%) (p=0.64). The age had significant influence on the disease outcome (p=0.019). The mean age of the deceased patients was 65.58±17.5 years, opposite to the mean age of the survived patients which was 53.04±16.8 years. The place of living of the patients had no significant influence on the outcome (p=0.44), that is, patients from rural environment died insignificantly more often than patients from urban environment (22.22% vs. 12.82%). Patients with positive epidemiological survey for influenza contacts died insignificant more often than patients with negative epidemiological survey of influenza contacts (p=0.52). In the group of patients with positive epidemiological survey of influenza contacts 16.36% died vs. 9.38% in the group of patients with negative epidemiological survey of influenza contacts. The patient who was vaccinated against influenza overcame the disease whereas 13.95% of the patients who were not vaccinated died (p=1.0) ( Table 1) .
The results showed that mortality in the group of patients with severe influenza without comorbidities was 9.09% against the group of patients with comorbidities where mortality was higher 15.38%. The difference in distribution between these two groups was statistically insignificant (p=0.72). The analysis of the different chronic conditions showed that those disease have significant influence on the outcome in patients with influenza (p=0.011). Mor-tality in the group with a negative history of cardiovascular disease was 4.55% vs. 23.26% in the group of patients with cardiovascular disease. This difference is statistically significant. All other analyzed comorbidities were insignificantly associated with the outcome in patients with influenza. A small number of patients who had weakened immune system, liver disorders, obesity and pregnancy survived although they presented with a severe form of influenza (Table 2, Fig. 1) .
Patients with influenza who died had insignificantly more comorbidities (p=0.085) ( Table 3) . Table 4 presents the results from the univariate logistic regression analysis in determining the analyzed demographic and comorbid variables that have confirmed to be predictors of the lethal outcome. Variables in the univariate logistic regression analysis, which were significantly associated with lethal outcome, were included in the multivariate logistic regression analysis in order to determine independent predictors for lethal outcome in patients with influenza. The results of these analyses showed that cardiovascular diseases were the only significant independent predictors for lethal outcome (p=0.014).
Patients with influenza and cardiovascular diseases had 2.024 times higher risk of death by influenza when compared to patients with influenza without history of cardiovascular comorbidity (OR=2.024 95% CI 1.842-17.337) ( Table 5 ). ROC analysis has demonstrated that cardiovascular disease is a good prognostic factor of the lethal outcome.
The area under the ROC curve, that is, AUC was 0.755, with 95% confidence interval from 0.587-0.923 suggesting that the probability of that predictor for death in influenza patients was 75.5%. The global precision of this predictor to foresee the lethal outcome was 80%, sensitivity was 82% and specificity 70%. Fig. 2 . ROC curve for the influence of cardiovascular diseases in prediction of lethal outcome from influenza
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Discussion
Gender, age and place of living were evaluated as demographic variables in our study. The results showed that from a total of 12 lethal outcomes 5 (16.1%) were women, and 7 (12.5%) were men. Regarding gender our study showed different results compared to a large number of studies, where male gender was identified as a risk factor for a severe form of influenza (Cao et al., 2009; Kumar et al., 2009 ). Our study is similar to that conducted in Canada where from a total number of 29 lethal outcomes, 27.6% were men, whereas 72.4% were women (Mata-Marín et al., 2015). There was no significant difference in the mortality between our male and female patients. The age had significant influence on the disease outcome in our study. The mean age of patients that died was 65.58 (p=0.019). The mortality was the highest in patients at the age over 65 (27.2%). These results coincide with almost all studies in the world that identify the old age as an important risk factor for mortality in patients with influenza Perez-Padilla et al., 2009; Rodríguez et al., 2010) . The place of living of the patients was not significant in relation to the outcome. Patients from both the rural and environments died, 22.2% vs. 12.8%.
Only one of our patients was vaccinated and he survived. Eighty-six (98.8%) patients were vaccinated, with mortality rate of 13.9%. Due to the small number of patients this difference between the two groups was insignificant. These results shoud be taken with precaution since many studies show that vaccination significantly reduces mortality rate of influenza (De Florentiis et al., 2010; Moa et al., 2016; Sridhar et al., 2015) .
The results obtained in our study have shown that the mortality rate in the group of patients with severe influenza without comorbidities was 9.09% whereas in the group of patients with associated comorbidities the mortality rate was higher (15.38%) (p=0.72). The analysis of identified associated chronic conditions has shown that cardiovascular diseases had significant influence on the outcome (p=0.011). Two (4.55%) of influenza patients with a negative history of cardiovascular comorbidity died, whereas a significantly higher percentage of patients with associated cardiovascular diseases died (23.26%). All other chronic diseases were insignificantly associated with the lethal outcome in influenza patients. A small number of patients who had immunological diseases (1), liver diseases (1), and obesity (2) in the group of severe form of influenza survived. Two pregnant women also survived. A large number of studies show that patients with one or more comorbidities needed to be hospitalized in intensive care units, and some of them were at a risk to die (Campbell et al., 2010; Kalyani1 et al., 2011) . Multivariate logistic regression analysis detected only cardiovascular diseases as independent risk factors for severe seasonal influenza and lethal outcome in our study. This is in correlation with a large number of studies, where besides cardiovascular diseases, many other comorbidities have been presented, such as pulmonology and immunological diseases. A large number of studies has detected pregnancy as a risk factor for complications and lethal outcome in a severe form of influenza, and emphasize that the highest risk is in last three months. (Jamieson et al., 2009; Louie et al., 2010) . However, one study did not detect any lethal outcome in a total of 211 pregnant women (Lim et al., 2010) . In our study pregnancy was not significantly associated with any complication, miscarriage, premature birth, fetal distress, severe clinical course and lethal outcome. This might be due to a small number of pregnant women included in our study, and one of them had early antiviral treatment.
Univariate logistic regression analysis for predicting the letal outcome in patients of sesonal influenza emphasized the age from the demongraphic variables (p=0.025) and cardiovascular diseases from comorbidities (p=0.022) as predictors for lethal outcome. The variables of the univariate analysis that showed a significant difference in terms of a lethal outcome were used to create multivariate logistic and regression analysis in order to determine the independent predictors for lethal outcome in patient with influenza. Our analysis determined cardiovascular diseases as an independent predictors for lethal outcome of severe seasonal influenza (p=0.014). Patients with influenza and cardiovascular diseases had 2.024 times higher risk of death of influenza compared to influenza patients without history of cardiovascular comorbidities (OR=2.024 95% CI 1.842-17.337).
Conclusion
Cardiovascular diseases were the most frequent comorbidity in our studi as an independent variable for the unfavorable outcome in patients with severe influenza. Early detection of patients with a high risk of a severe form of influenza can help in implementing adequate medical measures that will contribute to reducing the mortality rate from these diseases.
